Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Recruiting2
Not Yet Recruiting1
Unknown1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07833332Not ApplicableRecruiting

Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's Disease

NCT07649720Not ApplicableNot Yet RecruitingPrimary

NaviCam Patency Capsule to Verify Gastrointestinal Patency

NCT05387031Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

NCT03886324Not ApplicableUnknownPrimary

POISE I Pilot Study

Showing all 4 trials

Research Network

Activity Timeline